Batch COA / NAD200_20260524
NAD+200 mg · lot NAD200_20260524
Certificate of Analysis summary. Cite this URL. The signed PDF is not published for download.
- Product
- NAD+ 200 mg
- Lot
- NAD200_20260524
- Manufactured
- 2026-05-24
- Expiry
- 2028-05-23
- Form
- Lyophilized powder
- Packaging
- 10 vials / box
- Storage
- Store at 2–8 °C, protected from light.
- Release
- Passed specification
- Catalog
- NAD+ 200 mg
Test results
| Parameter | Method | Specification | Result | Status |
|---|---|---|---|---|
| Appearance | Visual | White to off-white lyophilized cake | Complies | Pass |
| Identification (HPLC) | HPLC | Retention time conforms to reference standard | Conforms | Pass |
| Assay / content | HPLC | 90.0% – 110.0% of label claim | 200 mg | Pass |
| Purity (HPLC) | HPLC | ≥ 99.0% | 99.42% | Pass |
| Related substances | HPLC | ≤ 1.0% | 0.52% | Pass |
| Water content | Karl Fischer | ≤ 3.0% | 1.18% | Pass |
| pH | Potentiometric | 6.5 – 8.0 | 7.08 | Pass |
| Residual solvent | USP | Meets USP requirements | Complies | Pass |
| Bacterial endotoxin | USP LAL | ≤ 0.5 EU/mg | < 0.10 EU/mg | Pass |
| Sterility | USP sterility | Sterile | Complies | Pass |
| Particulate matter | USP | Meets USP requirements | Complies | Pass |
Methods
- HPLC assay
- HPLC purity analysis
- Karl Fischer moisture determination
- USP sterility test
- USP bacterial endotoxin test
The tested batch complies with internal quality specifications.
Laboratory research use only. Not a medicinal product, not for human or veterinary use, not for diagnosis or treatment.
Signed PDF on request: orders@veniscy.com. Name the lot.